NCT01410318View on ClinicalTrials.gov

Progression of Early Subclinical Atherosclerosis

Active, not recruitingOBSERVATIONAL

Enrollment

4,184

Participants

Timeline

Start Date

June 14, 2010

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions

Atherosclerosis

Trial Locations (1)

28660

Ciudad Financiera del Grupo Santander, Boadilla del Monte

All Listed Sponsors

collaborator

Grupo Santander

UNKNOWN

lead

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

OTHER